Sonoma Pharmaceuticals (SNOA) Share-based Compensation Growth (1y) (2011 - 2026)
Sonoma Pharmaceuticals (SNOA) Share-based Compensation Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 5.26% |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | -36.59% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -0.11% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | -49.74% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -18.06% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 23.11% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | -65.00% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.12 Mn | -222,819.83 | 2.58 Mn | 1.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.75% |
| Mar 31, 2026 | 50.00% |
| Dec 31, 2025 | 830.77% |
| Sep 30, 2025 | 178.57% |
| Jun 30, 2025 | -46.73% |
| Mar 31, 2025 | 30.43% |
| Dec 31, 2024 | -90.71% |
| Sep 30, 2024 | -89.23% |
| Jun 30, 2024 | -39.55% |
| Mar 31, 2024 | -31.00% |
| Dec 31, 2023 | -42.15% |
| Sep 30, 2023 | 20.37% |
| Jun 30, 2023 | -17.29% |
| Mar 31, 2023 | -50.50% |
| Dec 31, 2022 | 332.14% |
| Sep 30, 2022 | 3,500.00% |
| Jun 30, 2022 | 282.14% |
| Mar 31, 2022 | 267.27% |
| Dec 31, 2021 | -39.78% |
| Sep 30, 2021 | -98.13% |